| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/03/2009 | EP1742628A4 Alternative forms of the phosphodiesterase-4 inhibitor n-cyclopropyl-1-{3-¬(1-oxidopryidin-3-yl)ethynyl phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide |
| 06/03/2009 | EP1696912A4 Pyrazolopyridines and analogs thereof |
| 06/03/2009 | EP1682546B1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 06/03/2009 | EP1330458B1 N-( 1,2,4 triazoloazinyl) thiophenesulfonamide compounds as herbicides |
| 06/03/2009 | EP1307454B1 Derivatives of variolin b |
| 06/03/2009 | CN101448829A 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
| 06/03/2009 | CN101448828A 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 06/03/2009 | CN101448827A Indole derivatives |
| 06/03/2009 | CN101448826A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/03/2009 | CN101445507A Method for preparing praziquantel |
| 06/03/2009 | CN100494199C Aspergillus fumigatus dardarin C analogue, and its synthesizing method and use |
| 06/03/2009 | CN100494198C Hexahydro-pyrazino-pyridino-indole dione, and its synthesis and use |
| 06/03/2009 | CN100494197C Hexahydro-pyrazino-pyridino-indole, and its systhesis and use |
| 06/03/2009 | CN100494196C Indole alkaloid derivative, and its preparing method and use |
| 06/03/2009 | CN100494195C Carboline carboxylate derivative, and its synthesizing method and use |
| 06/02/2009 | US7541464 7-azaindoles, pharmaceutical compositions and their therapeutic applications |
| 06/02/2009 | US7541463 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541368 Pyrazoles as inhibitors of tumor necrosis factor |
| 06/02/2009 | US7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 06/02/2009 | US7541366 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | CA2450868C Non-nucleoside reverse transcriptase inhibitors |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 05/28/2009 | WO2009067621A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | WO2009067481A1 Compounds for the treatment of hepatitis c |
| 05/28/2009 | WO2009067233A1 Beta carbolines and uses thereof |
| 05/28/2009 | WO2009067166A2 Non-nucleoside reverse transcriptase inhibitors |
| 05/28/2009 | WO2009065922A2 Organic compounds |
| 05/28/2009 | WO2009065921A2 Novel compounds |
| 05/28/2009 | WO2009065920A2 Compounds |
| 05/28/2009 | WO2009065919A2 Organic compounds |
| 05/28/2009 | WO2009065872A2 Processes for the synthesis of varenicline l-tartrate |
| 05/28/2009 | WO2008140646A3 Process for the synthesis of cmhtp and intermediates thereof |
| 05/28/2009 | US20090137624 anticancer agents; tyrosine kinase inhibitors based on pyrazole-3-amine linked through amine to fused heterocyclic ring such as benzimidazole, or imidazo[4,5-b]pyridine; e.g. N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-(1-(4-fluorophenyl)ethyl)-3H-imidazo[4,5-b]pyridin-5-amine |
| 05/28/2009 | US20090137622 Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 05/28/2009 | US20090137610 Spiro imidozole derivatives as ppar modulators |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
| 05/28/2009 | US20090137582 Pyrazolo-pyridinone derivatives and methods of use |
| 05/28/2009 | US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |
| 05/28/2009 | US20090136931 Novel fluorescent labeling compound |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090136448 Antiviral 2-Carboxy-Thiophene Compounds |
| 05/28/2009 | US20090134784 Carbazole-containing materials in phosphorescent light emitting diodes |
| 05/28/2009 | CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | CA2706391A1 Spiropiperidines for use as tryptase inhibitors |
| 05/28/2009 | CA2705834A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/28/2009 | CA2705599A1 New compounds |
| 05/28/2009 | CA2705596A1 New compounds |
| 05/28/2009 | CA2705405A1 New compounds |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062898A2 Spirocyclic cyclohexane derivatives |
| 05/27/2009 | EP2062893A1 Fused imidazoles for cancer treatment |
| 05/27/2009 | EP2062892A1 Hypertension-ameliorating agent |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2061794A2 2-phenoxy pyrimidinone analogues |
| 05/27/2009 | EP2061792A2 Azetidinone derivatives for the treatment of disorders of the lipid metabolism |
| 05/27/2009 | EP2061791A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism |
| 05/27/2009 | EP2061790A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 05/27/2009 | EP2061771A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
| 05/27/2009 | EP2061765A2 Serine-threonine protein kinase and parp modulators |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | EP1807419B1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/27/2009 | EP1679747B1 Organic thin film transistor |
| 05/27/2009 | EP1615925B1 Imidazopyridine derivatives as melanocortin receptor agonists |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101443334A Anti-viral compounds |
| 05/27/2009 | CN101443323A Substituted spirocyclic CGRP receptor antagonists |
| 05/27/2009 | CN101443010A Brain function-improving agent, and functional food containing the improving agent |
| 05/27/2009 | CN101443006A Novel benzylamine derivatives as CETP inhibitors |
| 05/27/2009 | CN101440093A Process for synthesizing paliperidone intermediate |
| 05/27/2009 | CN101440092A 2-indazole-4-aza indole-5-amino derivatives, and preparation and use thereof |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/26/2009 | US7538220 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 05/26/2009 | US7538120 e.g. 7-(4-bromo-2-chlorophenylamino)-8-chloroimidazo[1,2-a]pyridine-6-carboxylic acid (2-hydroxyethoxy)-amide; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic, antiinflammatory agent; rheumatoid arthritis |
| 05/26/2009 | US7538115 Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/26/2009 | CA2533685C Nitrogen-containing fused heterocyclic carboxylic acid compounds |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
| 05/26/2009 | CA2342211C Antibiotic compositions for treatment of the eye, ear and nose |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009064675A1 Mapk/erk kinase inhibitors |
| 05/22/2009 | WO2009064449A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/22/2009 | WO2009064274A1 Enantiomerically enriched imidazoazepinone compounds |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063992A1 Condensed pyridine derivative and use thereof |
| 05/22/2009 | WO2009063897A1 Prophylactic or ameliorating agent for psoriasis in the skin |
| 05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | WO2009062989A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |